II. Preparations
- Active Drug (DEA Schedule 1 Drug)
- Gamma Hydroxybutyrate
- Precursor Drugs (abused drugs that metabolize to GHB)
- 1,4-Butanedial (BD)
- Gamma-Butyrolactone (GBL)
- Street Names
- G
- Liquid E
- Liquid Ecstasy
- Liquid X
- Grievous Bodily Harm
- Easy Lay
- Cherry Meth
- Georgia Home Boy
III. Indications: No Medical Indications
- Illicit Uses
- Date Rape for sedation and incapacitation
- Recreational drug and Club Drug for sedation and euphoria
- Anabolic Steroid alternative in bodybuilding (for Growth Hormone secretion)
- Previous Medical Uses
- Surgical Anesthetic in Europe (1960 in France)
- Induce short term coma
- Narcolepsy (Sodium oxybate)
- Alcohol Withdrawal (Sodium oxybate)
- Opiate dependency
- Classified as a Schedule I Controlled Substance
- Non-prescription use banned in 1990 in U.S.
IV. Pharmacology
- Mechanism
- Derivative of Gamma Aminobutyric Acid (GABA)
- Agonist at GABA B Receptors
- Characteristics
- Colorless, odorless liquid
- Salty Taste
-
Pharmacokinetics
- Onset of effect within 15 to 30 minutes
- Peak activity at 20 to 60 minutes
- Half-Life: 20-50 minutes
- Effect decreases after 3-4 hours
V. Findings: Symptoms and Signs
- Early
- Euphoria
- Later
- Dizziness
- Drowsiness or Somnolence
- Sialorrhea
- Hypotonia
- Vomiting
- Amnesia or Memory Loss
- Pupil Changes (Miosis or Mydriasis)
- Overdose
VI. Adverse Effects (see above)
- High risk of Overdose (dose often unknown)
- Sixty deaths from GHB in 2000 due to Overdose
- Bradycardia
- Hypotension
- Hypothermia
- Respiratory depression or apnea
- Altered Level of Consciousness
- Seizure-like activity
- Coma
VII. Drug Interactions
- May be lethal in combination with drugs or Alcohol
VIII. Labs: GHB
- Detected by urine or Blood Gas chromatography
- Requires special testing by sensitive instrument
- Measurable only for 6-12 hours after ingestion
- Quickly excreted into urine
- Often cleared with first void
IX. Labs: Other
- See Unknown Ingestion
- Bedside Glucose
- Other Toxicology Screening (for other agents)
- Blood Alcohol Level
- Acetaminophen Level
- Salicylate Level
- Urine Drug Screening
X. Management
- GHB Intoxication
- Supportive care including airway management
- Intravenous Fluids
- Avoid Gastric Decontamination
- Unlikely benefit (GHB is rapidly absorbed) and risk of aspiration
- Consider Endotracheal Intubation
- Short-half life of hours (self-Extubation is common)
- Withdrawal Syndrome from frequent large dose GHB use
- See GHB Withdrawal
XI. References
- Galloway (1996) News of Cal Soc Addict Med 23(1):1
- Masom and Tomaszewski (2018) Crit Dec Emerg Med 32(11): 23
- Dyer (2001) Ann Emerg Med 37(2):147-52 [PubMed]
- Gahlinger (2004) Am Fam Physician 69:2619-27 [PubMed]